Today In Biotech: Palatin Technologies (PTN), Omeros Corporation (OMER), Biocept (BIOC), MannKind (MNKD), Synergy Pharmaceuticals (SGYP)

Palatin Technologies Climbs As Female Viagra Is Approved Palatin Technologies, Inc. (NYSEMKT: PTN) Palatin Technologies is having a great day in the market after Sprout Pharmaceuticals received FDA approval for Addyi; a female sexual dysfunction medication that’s being referred to as “female Viagra”. While Palatin Technologies is in no way connected to Sprout Pharmaceuticals, . … Read more

Omeros (OMER) Stock Is Down: Why Bulls Don’t Mind

Omeros Corporation (NASDAQ: OMER) Omeros had an absolutely incredible day in the market yesterday; gaining more than 77% in morning trading after releasing phase 2 study data. However, today the story has changed and OMER is riding the downtrend. Nonetheless, if you’re an OMER bull, chances are that you’re not concerned. Nonetheless, if this is … Read more

Today In Biotech: Omeros (OMER), AVEO Pharmaceuticals (AVEO), Synergy Pharmaceuticals (SGYP), Gilead Sciences (GILD

Omeros Stock Is Up On Positive Phase 2 Data Omeros Corporation (NASDAQ: OMER) OMER is having an absolutely incredible day in the market today after announcing positive data from its phase 2 study of OMS721. The treatment is designed to combat thrombotic microangiopathies; a rare group of life-threatening clotting disorders. The data released today showed … Read more